A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis

Haematologica

Volumn 96, Issue 4, 2011, Pages 500-506

  Girelli, Domenico ^a   Trombini, Paola ^b   Busti, Fabiana ^a   Campostrini, Natascia ^a   Sandri, Marco ^a   Pelucchi, Sara ^b   Westerman, Mark ^c   Ganz, Tomas ^c,d   Nemeth, Elizabeta ^c,d   Piperno, Alberto ^b   Camaschella, Clara ^e  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c Intrinsic LifeSciences LLC   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Hemochromatosis; Hepcidin; Iron challenge; Phlebotomy; Transferrin receptor 2

Indexed keywords

FERROUS SULFATE; HEPCIDIN; HFE PROTEIN; IRON; TRANSFERRIN RECEPTOR 2;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMATOLOGICAL PARAMETERS; HEMOCHROMATOSIS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; IRON ABSORPTION; IRON BLOOD LEVEL; IRON DEPLETION; IRON OVERLOAD; IRON STORAGE; PHLEBOTOMY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; PROVOCATION TEST; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TRANSFERRIN SATURATION;

ADULT; ANTIMICROBIAL CATIONIC PEPTIDES; FERRITINS; GENOTYPE; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON; MALE; MEMBRANE PROTEINS; MIDDLE AGED; RECEPTORS, TRANSFERRIN; TIME FACTORS;

EID: 79953868297     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2010.033449     Document Type: Article

References (36)

1. Camaschella C. Understanding iron home-ostasis through genetic analysis of haemochromatosis and related disorders. Blood. 2005;106(12):3710-3717.
2. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306(5704):2090-2093.
3. Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis J, et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile haemo -chromatosis. Nat Genet. 2003;33(1): 21-22.
4. Papanikolaou G, Samuels M E, Ludwig E H, MacDonald M L, Franchini P L, Dubé M P, et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile haemo -chromatosis. Nat Genet. 2004;36(1): 77-82.
5. Piperno A, Girelli D, Nemeth E, Trombini P, Bozzini C, Poggiali E, et al. Blunted hep-cidin response to oral iron challenge in HFE-related haemochromatosis. Blood. 2007;110(12):4096-4100.
6. van Dijk BA, Laarakkers CM, Klaver SM, Jacobs EM, van Tits LJ, Janssen MC, et al. Serum hepcidin levels are innately low in HFE-related haemochromatosis but differ between C282Y-homozygotes with elevat- ed and normal ferritin levels. Br J Haematol. 2008;142(6):979-985.
7. Ganz T, Olbina G, Girelli D, Nemeth E, Westerman M. Immunoassay for human serum hepcidin. Blood. 2008;112(10):4292-4297.
8. Nemeth E, Roetto A, Garozzo G, Ganz T, Camaschella C. Hepcidin is decreased in TFR2 haemochromatosis. Blood. 2005; 105(4):1803-1806.
9. Pelucchi S, Mariani R, Trombini P, Coletti S, Pozzi M, Paolini V, et al. Expression of hep-cidin and other iron-related genes in type 3 haemochromatosis due to a novel mutation in transferrin receptor-2. Haematologica. 2009;94(2):276-279.
10. Muckenthaler M, Roy CN, Custodio AO, Miñana B, deGraaf J, Montross LK, et al. Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse haemochromatosis. Nat Genet. 2003;34(1):102-107.
11. Kawabata H, Fleming RE, Gui D, Moon SY, Saitoh T, O'Kelly J, et al. Expression of hep-cidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary haemochromatosis. Blood. 2005;105 (1):376-381.
12. Niederkofler V, Salie R, Arber S. Hemo -juvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. J Clin Invest. 2005;115(8): 2180-6.
13. Huang FW, Pinkus JL, Pinkus GS, Fleming MD, Andrews NC. A mouse model of juvenile haemochromatosis. J Clin Invest. 2005;115(8):2187-2191.
14. Johnson MB, Enns CA. Diferric transferrin regulates transferrin receptor 2 protein stability. Blood. 2004;104(13):4287-4293.
15. Johnson MB, Chen J, Murchison N, Green FA, Enns CA. Transferrin receptor 2: evidence for ligand-induced stabilization and redirection to a recycling pathway. Mol Biol Cell. 2007;18(3):743-754.
16. Goswami T, Andrews NC. Hereditary haemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. J Biol Chem. 2006;281(39):28494-28498.
17. Gao J, Chen J, Kramer M, Tsukamoto H, Zhang AS, Enns CA. Interaction of the hereditary haemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression. Cell Metab. 2009;9(3):217-227.
18. Pietrangelo A, Caleffi A, Henrion J, Ferrara F, Corradini E, Kulaksiz H, et al. Juvenile haemochromatosis associated with pathogenic mutations of adult haemochromato-sis genes. Gastroenterology. 2005;128(2): 470-479.
19. Lin L, Valore EV, Nemeth E, Goodnough JB, Gabayan V, Ganz T. Iron transferrin regu- lates hepcidin synthesis in primary hepato-cyte culture through hemojuvelin and BMP2/4. Blood. 2007;110(6):2182-2189.
20. Girelli D, Bozzini C, Roetto A, Alberti F, Daraio F, Colombari R, et al. Clinical and pathologic findings in haemochromatosis type 3 due to a novel mutation in transfer-rin receptor 2 gene. Gastroenterology. 2002;122(5):1295-1302.
21. Gandon Y, Olivié D, Guyader D, Aubé C, Oberti F, Sebille V, et al. Non-invasive assessment of hepatic iron stores by MRI. Lancet. 2004;363(9406):357-362.
22. Swinkels DW, Girelli D, Laarakkers C, Kroot J, Campostrini N, Kemna EH, et al. Advances in quantitative hepcidin measurements by time-of-flight mass spectrom-etry. PLoS One. 2008;3(7):e2706.
23. Campostrini N, Castagna A, Zaninotto F, Bedogna V, Tessitore N, Poli A, et al. Evaluation of hepcidin isoforms in hemo -dialysis patients by a proteomic approach based on SELDI-TOF MS. J Biomed Biotechnol. 2010;2010:329646.
24. Yeh KC, Kwan KC. A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximation. J Pharmacokinet Biopharm. 1978; 6(1):79-98.
25. Castagna A, Campostrini N, Zaninotto F and Girelli D. Hepcidin assay in serum by SELDI-TOF-MS and other approaches. J Proteomics. 2010;73(3):527-536.
26. Kroot JJ, Hendricks JC, Laarakkers CM, Klaver SM, Kemna EH, Tjalsma H, et al. (Pre)analytical imprecision, between-subject variability, and daily variations in serum and urine hepcidin: implications for clinical studies. Anal Biochem. 2009;389 (2):124-129.
27. Zimmermann MB, Troesch B, Biebinger R, Egli I, Zeder C, Hurrell RF. Plasma hepcidin is a modest predictor of dietary iron bioavailability in humans, whereas oral iron loading, measured by stable-isotope appearance curves, increases plasma hep-cidin. Am J Clin Nutr. 2009;90(5):1280-1287.
28. Ramos E, Phung Y, Gabayan V, Ganz T, Nemeth E. The pathogenesis of hereditary haemochromatosis. International Bioiron Society Meeting. Porto. June 7-11, 2009.
29. Wallace DF, Summerville L, Crampton EM, Frazer DM, Anderson GJ, Subramaniam VN. Combined deletion of Hfe and trans-ferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload. Hepatology. 2009;50(6):1992-2000.
30. Piperno A, Roetto A, Mariani R, Pelucchi S, Corengia C, Daraio F, et al. Homozygosity for transferrin receptor-2 Y250X mutation induces early iron overload. Haematologica. 2004;89(3):359-360.
31. Le Gac G, Mons F, Jacolot S, Scotet V, Ferec C and Frebourg T. Early onset hereditary haemochromatosis resulting from a novel TFR2 gene nonsense mutation (R105X) in two siblings of north French descent. Br J Haematol. 2004;125(5):674-678.
32. Biasiotto G, Camaschella C, Forni GL, Polotti A, Zecchina G, Arosio P. New TFR2 mutations in young Italian patients with haemochromatosis. Haematologica. 2008; 93(2):309-310.
33. Kroot JJ, Kemna EH, Bansal SS, Busbridge M, Campostrini N, Girelli D, et al. Results of the first international round robin for the quantification of urinary and plasma hep-cidin assays: need for standardization. Haematologica. 2009;94(12):1748-1752.
34. Valenti L, Girelli D, Valenti GF, Castagna A, Como G, Campostrini N, et al. HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients. Clin J Am Soc Nephrol. 2009;4(8): 1331-1337.
35. Zaritsky J, Young B, Wang H, Westerman M, Olbina G, Nemeth E, et al. Hepcidin-a potential novel biomarker for iron status in chronic kidney disease. Clin J Am Soc Nephrol. 2009;4(6):1051-1056.
36. Kroot JJC, Laarakkers CMM, Geurts-Moespot AJ, Grebenchtchikov N, Pikkers P, van Ede A, et al. Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders. Clin Chem. 2010;56(10):1570-1579.